Ryan Moskowitz Email & Phone Number

Alpharetta, Georgia, Us

ModifyHealth changes lives by making food as medicine simple and sustainable. Our turnkey programs improve outcomes and cost for chronic conditions such as diabetes, heart disease, kidney disease, irritable bowel syndrome (IBS), and related GI issues where dietary management is a recommended treatment.Along with home-delivered, Low FODMAP, gluten-free, Mediterranean, and low sodium meals, ModifyHealth provides dietitian coaching & support and remote patient monitoring to ensure sustained benefits. We partner with providers, payors, employers, and patients to make adopting healthier diets and lifestyles a reality.

From startups to Fortune 100 brands, JacksonKate is a strategic, award winning, brand development and design agency known for its impactful creative ideas that generate powerful emotional connections between consumers and brands. Specializing in Luxury, MedTech, SaaS, Finance, Loyalty, Subscription, & Retail.

Stockholm, Se

Syncron empowers the world’s leading manufacturers to maximize product uptime and deliver exceptional after-sales service experiences, while driving significant revenue and profit improvements. From industry leading investments in research and development, to providing the fastest time-to-value, Syncron’s award-winning, cloud-based service parts inventory, price, order and uptime management solutions are designed to continually exceed customer expectations. Top brands from around the world trust Syncron to transform their after-sales service operations into competitive differentiators. For more information, visit syncron.com.

Alpharetta, Ga, Us

EndoChoice is a medical technology company serving physicians in gastrointestinal (GI) endoscopy. The Company is focused on R&D and commercialization, delivering a broad portfolio of innovative devices and diagnostics. The Company's lead investor is Sequoia Capital and has been recognized 6 consecutive years by Inc. Magazine as one of the fastest growing companies in America. EndoChoice completed its IPO on the New York Stock Exchange (NYSE: GI). EndoChoice was acquired by Boston Scientific in November 2016.

Fort Lauderdale, Fl, Us